Novo Nordisk Notice on COVID-19, Rebinyn® and Laboratory Assays

Novo Nordisk recently distributed a notice relevant to its product Rebinyn®, raising awareness that one-stage clotting assay results can be significantly affected by the type of activated partial thromboplastin time (aPTT) reagent used, which can result in over or under-estimation of Factor IX activity.The notice which was addressed to HTCs, physicians and other healthcare providers, includes […]